We are live on ! Find out more
KPRX icon

Kiora Pharmaceuticals
KPRX

12 hedge funds and large institutions have $1.93M invested in Kiora Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

33% more funds holding

Funds holding: 9 → 12 (+3)

0% less ownership

Funds ownership: 0% → 0% (-0%)

20% less capital invested

Capital invested by funds: $2.4M → $1.93M (-$470K)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
12
Holders Change
+3
Holders Change %
+33.33%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$61.9K
2
Citadel Advisors
Citadel Advisors
Florida
+$37.1K
3
Macquarie Group
Macquarie Group
Australia
+$30.9K
4
WS
Wedbush Securities
California
+$24.7K
5
Northern Trust
Northern Trust
Illinois
+$6.18K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$377K
2
SM
Sabby Management
Florida
-$54K
3
CS
Credit Suisse
Switzerland
-$12.4K
4
IA
IFP Advisors
Florida
-$6.18K
5
Bank of America
Bank of America
North Carolina
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$1.37M -$377K -61 -20%
Vanguard Group
2
Vanguard Group
Pennsylvania
$287K – – –
VF
3
Virtu Financial
New York
$77K +$61.9K +10 +333%
Citadel Advisors
4
Citadel Advisors
Florida
$34K +$37.1K +6 New
TSS
5
Two Sigma Securities
New York
$33K – – –
Macquarie Group
6
Macquarie Group
Australia
$27K +$30.9K +5 New
IA
7
IFP Advisors
Florida
$25K -$6.18K -1 -20%
CS
8
Credit Suisse
Switzerland
$21K -$12.4K -2 -33%
WS
9
Wedbush Securities
California
$21K +$24.7K +4 New
Northern Trust
10
Northern Trust
Illinois
$16K +$6.18K +1 +50%
VIA
11
Vantage Investment Advisors
Pennsylvania
$7K – – –
UBS Group
12
UBS Group
Switzerland
$5K +$6.18K +1 New
HFP
13
Holistic Financial Partners
Indiana
$2K – – –
WTB
14
Washington Trust Bank
Washington
$2K – – –
BlackRock
15
BlackRock
New York
$1K – – –
Morgan Stanley
16
Morgan Stanley
New York
$1K – – –
Wells Fargo
17
Wells Fargo
California
$1K – – –
SM
18
Sabby Management
Florida
– -$54K -9 Closed
Bank of America
19
Bank of America
North Carolina
– -$1K – –

KPRX Hedge Fund Activity: Q4 2017 in Review

12 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Kiora Pharmaceuticals (KPRX) for Q4 2017, worth a combined $1.93M — down 20% from $2.4M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new KPRX positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Virtu Financial, adding an estimated $61.9K. The largest seller was Armistice Capital, cutting an estimated $377K.

  • 12 institutional investors held Kiora Pharmaceuticals (KPRX) as of Q4 2017, up from 9 in Q3 2017.
  • Funds reported $1.93M of Kiora Pharmaceuticals stock for Q4 2017, down 20% quarter-over-quarter.
  • 4 funds opened new Kiora Pharmaceuticals positions in Q4 2017 and 1 closed out, a net change of +3 holders.
  • The largest Kiora Pharmaceuticals buyer in Q4 2017 was Virtu Financial, an estimated $61.9K added.
  • The largest Kiora Pharmaceuticals seller in Q4 2017 was Armistice Capital, an estimated $377K sold.

Based on aggregated 13F filings for Q4 2017.